Eneida R. Nemecek

1.6k total citations
31 papers, 588 citations indexed

About

Eneida R. Nemecek is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Eneida R. Nemecek has authored 31 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 7 papers in Oncology. Recurrent topics in Eneida R. Nemecek's work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Eneida R. Nemecek is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Eneida R. Nemecek collaborates with scholars based in United States, Canada and South Africa. Eneida R. Nemecek's co-authors include Ann E. Woolfrey, Frederick R. Appelbaum, Dana C. Matthews, John M. Pagel, Ted Gooley, Richard T. Maziarz, Jean E. Sanders, Darrell R. Fisher, Paul A. Carpenter and Oliver W. Press and has published in prestigious journals such as Blood, Clinical Cancer Research and Supportive Care in Cancer.

In The Last Decade

Eneida R. Nemecek

31 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eneida R. Nemecek United States 14 404 176 161 122 78 31 588
H Espérou-Bourdeau France 11 428 1.1× 155 0.9× 120 0.7× 81 0.7× 20 0.3× 22 539
Minako Iida Japan 7 290 0.7× 82 0.5× 102 0.6× 105 0.9× 17 0.2× 13 436
Asmita Mishra United States 15 411 1.0× 87 0.5× 234 1.5× 72 0.6× 20 0.3× 63 672
S. Wittebol Netherlands 10 387 1.0× 107 0.6× 272 1.7× 78 0.6× 40 0.5× 16 581
A Rosenmayr Austria 10 374 0.9× 62 0.4× 97 0.6× 256 2.1× 23 0.3× 20 522
Shannon R. McCurdy United States 17 602 1.5× 150 0.9× 219 1.4× 266 2.2× 12 0.2× 70 737
Michael Gratwohl Switzerland 8 398 1.0× 144 0.8× 134 0.8× 86 0.7× 8 0.1× 9 521
C-K Min South Korea 13 460 1.1× 200 1.1× 112 0.7× 156 1.3× 9 0.1× 20 558
Ryan Jacobs United States 12 182 0.5× 93 0.5× 176 1.1× 113 0.9× 121 1.6× 59 505

Countries citing papers authored by Eneida R. Nemecek

Since Specialization
Citations

This map shows the geographic impact of Eneida R. Nemecek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eneida R. Nemecek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eneida R. Nemecek more than expected).

Fields of papers citing papers by Eneida R. Nemecek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eneida R. Nemecek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eneida R. Nemecek. The network helps show where Eneida R. Nemecek may publish in the future.

Co-authorship network of co-authors of Eneida R. Nemecek

This figure shows the co-authorship network connecting the top 25 collaborators of Eneida R. Nemecek. A scholar is included among the top collaborators of Eneida R. Nemecek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eneida R. Nemecek. Eneida R. Nemecek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williamson, Staci, Levanto Schachter, Andy Chen, et al.. (2024). Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 25(2). e120–e125. 4 indexed citations
2.
Nagle, Sarah, Philipp W. Raess, Levanto Schachter, et al.. (2021). Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies. American Journal of Hematology. 96(4). 455–461. 44 indexed citations
3.
Chaudhury, Sonali, Eneida R. Nemecek, Kris M. Mahadeo, et al.. (2018). A Phase 3 Single-Arm, Prospective Study of Remestemcel-L, Ex-Vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Steroid Refractory Acute Gvhd in Pediatric Patients. Biology of Blood and Marrow Transplantation. 24(3). S171–S172. 6 indexed citations
4.
5.
Carpenter, Paul A., Brent R. Logan, Stephanie J. Lee, et al.. (2016). Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network. Biology of Blood and Marrow Transplantation. 22(3). S50–S52. 3 indexed citations
6.
Cuvelier, Geoff D.E., Eneida R. Nemecek, Michael Boyer, et al.. (2016). National Institutes of Health (NIH) Consensus Criteria Describe the Clinical Features of Chronic Graft-Versus-Host Disease (cGVHD) in Children and Improve the Accuracy of cGVHD Diagnosis in a Multi-Institution Trial (ABLE / PBMTC 1202). Biology of Blood and Marrow Transplantation. 22(3). S104–S105. 1 indexed citations
7.
Burroughs, Lauri M., Eneida R. Nemecek, Troy R. Torgerson, et al.. (2014). Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial. Biology of Blood and Marrow Transplantation. 20(12). 1996–2003. 38 indexed citations
8.
Majhail, Navneet S., Pintip Chitphakdithai, Brent R. Logan, et al.. (2014). Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era. Biology of Blood and Marrow Transplantation. 21(1). 142–150. 46 indexed citations
9.
10.
Gyurkocza, Boglarka, Jonathan A. Gutman, Eneida R. Nemecek, et al.. (2014). Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 20(4). 549–555. 42 indexed citations
11.
Shereck, Evan, Shalini Shenoy, Michael A. Pulsipher, et al.. (2013). Exposure of Early Pediatric Trainees to Blood and Marrow Transplantation Leads to Higher Recruitment to the Field. Biology of Blood and Marrow Transplantation. 19(9). 1399–1402. 5 indexed citations
12.
Sutton, Kathryn S., Evan Shereck, Eneida R. Nemecek, & Peter Kurre. (2012). Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia. Pediatric Blood & Cancer. 60(3). 455–460. 14 indexed citations
13.
Nemecek, Eneida R., Wensheng He, Nancy Bunin, et al.. (2011). Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission. Biology of Blood and Marrow Transplantation. 17(12). 1833–1840. 13 indexed citations
14.
Burroughs, Lauri M., Troy R. Torgerson, Barry E. Storer, et al.. (2011). Nonmyeloablative Conditioning Followed by Allogeneic Marrow Grafts for Treatment of Primary Immune Deficiency Disorders: Preliminary Results of a Phase II Study. Biology of Blood and Marrow Transplantation. 17(2). S181–S182. 2 indexed citations
15.
Nemecek, Eneida R., Katherine A. Guthrie, Mohamed L. Sorror, et al.. (2010). Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 17(3). 341–350. 74 indexed citations
16.
Jacobsohn, David A., Andrew L. Gilman, Alfred Rademaker, et al.. (2009). Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Blood. 114(20). 4354–4360. 28 indexed citations
17.
18.
Pagel, John M., Frederick R. Appelbaum, Janet F. Eary, et al.. (2005). 131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood. 107(5). 2184–2191. 107 indexed citations
19.
Nemecek, Eneida R., Ted Gooley, Ann E. Woolfrey, et al.. (2004). Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplantation. 34(9). 799–806. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Espérou-Bourdeau Breakdown of academic impact, for papers by Minako Iida Breakdown of academic impact, for papers by Asmita Mishra Breakdown of academic impact, for papers by S. Wittebol Breakdown of academic impact, for papers by A Rosenmayr Breakdown of academic impact, for papers by Shannon R. McCurdy Breakdown of academic impact, for papers by Michael Gratwohl Breakdown of academic impact, for papers by C-K Min Breakdown of academic impact, for papers by Ryan Jacobs
Rankless by CCL
2026